BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34980138)

  • 1. CBX4-dependent regulation of HDAC3 nuclear translocation reduces Bmp2-induced osteoblastic differentiation and calcification in adamantinomatous craniopharyngioma.
    Yan X; Kang D; Lin Y; Qi S; Jiang C
    Cell Commun Signal; 2022 Jan; 20(1):3. PubMed ID: 34980138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoblastic differentiation and cell calcification of adamantinomatous craniopharyngioma induced by bone morphogenetic protein-2.
    Yan X; Kang D; Pan J; Jiang C; Lin Y; Qi S
    Cancer Biomark; 2017; 18(2):191-198. PubMed ID: 27983534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does the calcification of adamantinomatous craniopharyngioma resemble the calcium deposition of osteogenesis/odontogenesis?
    Song-Tao Q; Xiao-Rong Y; Jun P; Yong-Jian D; Jin L; Guang-Long H; Yun-Tao L; Jian R; Xiang-Zhao L; Jia-Ming X
    Histopathology; 2014 Feb; 64(3):336-47. PubMed ID: 24387671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CBX4 Suppresses Metastasis via Recruitment of HDAC3 to the Runx2 Promoter in Colorectal Carcinoma.
    Wang X; Li L; Wu Y; Zhang R; Zhang M; Liao D; Wang G; Qin G; Xu RH; Kang T
    Cancer Res; 2016 Dec; 76(24):7277-7289. PubMed ID: 27864346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-myc Downstream-Regulated Gene 2 (NDRG2) Promotes Bone Morphogenetic Protein 2 (BMP2)-Induced Osteoblastic Differentiation and Calcification by Janus Kinase 3 (JAK3)/Signal Transducer and Activator of Transcription 3 (STAT3) Signaling Pathway.
    Chen S; Wang J; Cai C; Xie X
    Med Sci Monit; 2020 Jan; 26():e918541. PubMed ID: 31911574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calretinin is expressed in the stroma of adamantinomatous craniopharyngioma and may induce calcification.
    Chaohu W; Yi L; Hai H; Hui Z; Jun P; Song-Tao Q
    Clin Neurol Neurosurg; 2015 Nov; 138():124-8. PubMed ID: 26319618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conditioned medium from bone marrow-derived mesenchymal stem cells inhibits vascular calcification through blockade of the BMP2-Smad1/5/8 signaling pathway.
    Wang S; Hu S; Wang J; Liu Y; Zhao R; Tong M; Cui H; Wu N; Chen X
    Stem Cell Res Ther; 2018 Jun; 9(1):160. PubMed ID: 29895327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stromal cell-derived factor-1 promotes osteoblastic differentiation of human bone marrow mesenchymal stem cells via the lncRNA-H19/miR-214-5p/BMP2 axis.
    He Q; Li R; Hu B; Li X; Wu Y; Sun P; Jia Y; Guo Y
    J Gene Med; 2021 Sep; 23(9):e3366. PubMed ID: 34032330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug priming enhances radiosensitivity of adamantinomatous craniopharyngioma via downregulation of survivin.
    Stache C; Bils C; Fahlbusch R; Flitsch J; Buchfelder M; Stefanits H; Czech T; Gaipl U; Frey B; Buslei R; Hölsken A
    Neurosurg Focus; 2016 Dec; 41(6):E14. PubMed ID: 27903123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA KCNQ1OT1 promoted BMP2 expression to regulate osteogenic differentiation by sponging miRNA-214.
    Wang CG; Liao Z; Xiao H; Liu H; Hu YH; Liao QD; Zhong D
    Exp Mol Pathol; 2019 Apr; 107():77-84. PubMed ID: 30703347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1,25(OH)2D3 inhibits osteogenic differentiation through activating β‑catenin signaling via downregulating bone morphogenetic protein 2.
    Han X; Zhu N; Wang Y; Cheng G
    Mol Med Rep; 2020 Dec; 22(6):5023-5032. PubMed ID: 33173996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylase 3 interacts with runx2 to repress the osteocalcin promoter and regulate osteoblast differentiation.
    Schroeder TM; Kahler RA; Li X; Westendorf JJ
    J Biol Chem; 2004 Oct; 279(40):41998-2007. PubMed ID: 15292260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin‑6 induces an epithelial‑mesenchymal transition phenotype in human adamantinomatous craniopharyngioma cells and promotes tumor cell migration.
    Zhou J; Zhang C; Pan J; Chen L; Qi ST
    Mol Med Rep; 2017 Jun; 15(6):4123-4131. PubMed ID: 28487953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BMP2 regulates Osterix through Msx2 and Runx2 during osteoblast differentiation.
    Matsubara T; Kida K; Yamaguchi A; Hata K; Ichida F; Meguro H; Aburatani H; Nishimura R; Yoneda T
    J Biol Chem; 2008 Oct; 283(43):29119-25. PubMed ID: 18703512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiplexed immunofluorescence reveals potential PD-1/PD-L1 pathway vulnerabilities in craniopharyngioma.
    Coy S; Rashid R; Lin JR; Du Z; Donson AM; Hankinson TC; Foreman NK; Manley PE; Kieran MW; Reardon DA; Sorger PK; Santagata S
    Neuro Oncol; 2018 Jul; 20(8):1101-1112. PubMed ID: 29509940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt/β-catenin pathway regulates bone morphogenetic protein (BMP2)-mediated differentiation of dental follicle cells.
    Silvério KG; Davidson KC; James RG; Adams AM; Foster BL; Nociti FH; Somerman MJ; Moon RT
    J Periodontal Res; 2012 Jun; 47(3):309-19. PubMed ID: 22150562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone deacetylase 8 suppresses osteogenic differentiation of bone marrow stromal cells by inhibiting histone H3K9 acetylation and RUNX2 activity.
    Fu Y; Zhang P; Ge J; Cheng J; Dong W; Yuan H; Du Y; Yang M; Sun R; Jiang H
    Int J Biochem Cell Biol; 2014 Sep; 54():68-77. PubMed ID: 25019367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-135-5p promotes osteoblast differentiation by targeting HIF1AN in MC3T3-E1 cells.
    Yin N; Zhu L; Ding L; Yuan J; Du L; Pan M; Xue F; Xiao H
    Cell Mol Biol Lett; 2019; 24():51. PubMed ID: 31410089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-409-3p promotes osteoblastic differentiation via activation of Wnt/β-catenin signaling pathway by targeting SCAI.
    Chen N; Yang H; Song L; Li H; Liu Y; Wu D
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33274736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-195 functions as a tumor suppressor by inhibiting CBX4 in hepatocellular carcinoma.
    Zheng C; Li J; Wang Q; Liu W; Zhou J; Liu R; Zeng Q; Peng X; Huang C; Cao P; Cao K
    Oncol Rep; 2015 Mar; 33(3):1115-22. PubMed ID: 25607636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.